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ABSTRACT 
Toxoplasma gondii is a protozoan parasite that infects up to a third of the world’s population. 
Infection is mainly acquired by ingestion of food or water that is contaminated with oocysts 
shed by cats or by eating undercooked or raw meat containing tissue cysts. Primary maternal 
infection with toxoplasmosis during pregnancy is frequently associated with transplacental 
transmission to the fetus. Although Toxoplasma gondii infection generally shows subclinical 
courses in adults, it may have severe pathologic effects on the fetus. Infection in pregnant 
women may lead to abortion, stillbirth or other serious consequences in newborns. This study 
was conducted to test the utility of a polymerase chain reaction (PCR) assay to detect recent 
infections with Toxoplasma in abortive women. Two hundred placentas from aborted women 
in various gestational ages and with a history of abortion, admitted in Alavi Obstetric and 
Gynecological department of Ardabil were collected during 2013 to 2014. The placenta was 
tested by nested PCR, using fragments of the GRA6 gene. Using PCR method, 17 out of 200 
(8.5%) samples of spontaneous aborted placenta were found to be positive for T. Gondii. A 
significant relationship was not observed between the presences of Toxoplasma, mother's 
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age, and history of abortion, gestational age and illnesses such as allergy, diabetes, 
hypertension and hypothyroidism. 
The present findings reveals that Toxoplasma gondii may be one of the potential agents in 
causing significant rate of abortion in the Ardabil area and placenta analysis is important to 
improve the sensitivity of the diagnosis . 
Keywords: Toxoplasma gondii, Abortion, Nested-PCR, Iran 
INTRODUCTION 
Toxoplasmosis is a parasitic infection 
disease which is caused by Toxoplasma 
gondii and courses with various clinical 
findings. Up to one-third of the human 
population in the world is chronically 
infected (1). Human infection generally 
occurs by ingestion of tissue cyst in raw or 
undercooked meat or by ingestion of 
parasite oocytes shed in feces of cat that 
contaminate water and food sources. 
Congenital transmission is the other route 
of infection (2). 
Congenital toxoplasmosis generally occurs 
when a woman is newly infected with T. 
gondii during pregnancy (3). Congenital 
infection can lead to a wide variety of 
manifestations in the fetus and infant 
including spontaneous abortion, still-birth, 
a live infant with classic signs of congenital 
toxoplasmosis such as hydrocephalus or 
microcephalus, cerebral calcifications and 
retinochorioditis, an infant who fails to 
thrive or has CNS involvement or 
retinochoroiditis, or an apparently normal 
infant who develops retinochoroiditis or 
symptoms of CNS involvement later in life 
(3-4).Development of fetal infection and 
the severity of sequels that may develop are 
related to the gestational week (5-6). The 
incidence of congenital infection is 10-25% 
in the first trimester, 30-54% in the second 
trimester and 60-65% in the last trimester5-
9. While the transplacental transmission 
appears to be less frequent in early 
pregnancy, the sequels occurring are more 
severe. The transmission rate is higher in 
latent period but the severity of the 
infection developing in fetus is mild. Mild 
symptoms may develop in fetus or they are 
asymptomatic in delivery (7-8-9).                 
It has been estimated that congenital 
toxoplasmosis affects 1 to 10 per 10,000 
infants in Europe (10). In Iran the rate of 
abortion due to congenital toxoplasmosis is 
unclear in many areas where the rate of 
acquired toxoplasmosis is reasonably high. 
up to present, most of the decisions on 
infected fetuses were made based on 
serological findings in their mothers, which 
might have led to abortion of many 
uninfected fetuses.                                        
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The dense granule of T. gondii is a 
secretory vesicular organelle, which 
produces proteins that participate in the 
modification of the parasitophorous 
vacuole (PV) and PV membrane for the 
maintenance of intracellular parasitism in 
almost all nucleated host cells (11). GRA6 
is considered a good marker of acute 
infection (12-13-14). 
In the present study, the role of Toxoplasma 
gondii in abortion in human was evaluated 
by molecular method in Ardabil city (north-
west of Iran).  
MATERIALS AND METHODS 
This study has been performed on two 
hundred women in various gestational ages 
and with a history of single or repeated 
abortion, admitted in Alavi Obstetric and 
Gynecological department of Ardabil in 
one year during 2013 to 2014. 
a- Sample collection: 
Around 20gr placenta from the patient was 
cut in a sterile form and kept at −20°C until 
further testing. Information collected on 
patients were age , abortion history and 
pregnancy levels.  
b- DNA extraction and PCR detection : 
T. gondii DNA was extracted from 
placenta of abortive women using the 
QIAamp DNA mini kit (Qiagen, France). 
Tissues were cut with maximum weight of 
50 mg and placed in micro tube with the 
addition of 180 µl   ALT buffer 20 µl 
proteinase k and fallowed with vortexing 
and incubated at 56°C until the tissue was 
completely lysed.  Then 200 µl buffers AL 
was added to the sample and heated at 70°C 
for 10 min.200 µl ethanol (96 – 100%) was 
added to the samples and then 2 ml mini 
spin column was applied and centrifuged 
for 1 min at 6000 Xg. The mini spin 
column  was placed in a clean 2ml 
collection tube and 500 µl  buffer AW1 
was added  to  it and it was centrifuged at 
6000Xg for 1min and followed by placing 
another collection tube and adding 500 µl 
buffer AW2 and  it was centrifuged at full 
speed for 3min and again spin column was  
placed  in  a new 2 ml collection tube and 
centrifuged at full speed for 1 min spin 
column was placed again in 
microcentrifuge tube and 50 µl   buffer AE 
was added to spin column and incubated at  
room  temperature for 1 min and 
centrifuged at 6000Xg for 1 min. DNA 
samples was stored at -20°C .  
Nested primer sets were used for 
amplifying fragments of the GRA6 gene as 
described by Khan et al. (2005), a 
modification of the GRA6 marker 
originally described by Fazaeli et al. 
(2000). 
 The external primers were GRA6-F1x (5-
ATTTGTGTTTCCGAGCAGGT-3) and 
GRA6-R1 (GCACCTTCGCTTGTGGTT) 
producing an amplified product of 546 bp. 
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producing an amplified product of 351 bp. 
The first25 μL of PCR reaction mixture 
contained outer primers at a final 
concentration of 50 pmol each, 2.5 mmol 
dNTPs, 1 μg of template, and 1.5 U 
recombinant taq DNA polymerase, in 1× 
PCR reaction buffer (50 mmol/L KCl 
and10 mmol/L Tris–HCl, 1.5 mmol/L 
MgCl2, and 0.1% triton X-100; Sinagen 
Co., Iran). 
The first step of amplification was 5 min of 
denaturation at 94°C. This step was 
followed by 40 cycles, with one cycle 
consisting of 45 s at 94°C, 45 s at the 
annealing temperature (55°C) for each pair 
of primers, and 60 s at 72°C. The final 
cycle was followed by an extension step of 
10 min at 72°C. 
The nested PCR reaction was performed 
using 1 μL of the first PCR reaction in a 
mixture containing the inner primers at 
final concentration of 50 pmol each, 2.5 
mmol/L dNTPs, and 1.5 U recombinant taq 
DNA polymerase in 1× PCR reaction 
buffer. Amplification was carried out at 
94°C for 5 min (one cycle), then followed 
by 40 cycles each for denaturation at 94°C 
for 45 s, annealing at 55°C for 45 s, and 
extension at 72°C for 45 s. The run was 
terminated with a final extension at 72°C 
for 10 min. The amplification products 
were detected by gel electrophoresis using 
2% agarose gel in 1× Tris–borate–EDTA 
buffer. DNA bands were visualized in the 
presence of ultraviolet light, following the 
staining with 0.5% ethidium bromide. 
RESULT 
A total of 200 abortive women were 
recruited. Their age range was from 16 to 
41 years with a mean of 30.5 years. The 
majority of these women (44 %) were 
between 20 and 30 year, Most of these 
pregnant women (53%) were in their first 
trimester of pregnancy and73. % has one or 
no child and 71%   had no experience of 
miscarriage (Table 1). As observed in 
Figure 1, 8 cases (4%) had history of 
hypothyroidism, 9 cases (4.5%) diabetes, 
13 cases allergy(6.5%) ,2 cases 
hypertension(4%) and 168 cases(85%) had 
history of no diseases except miscarriage 
(fig1).  
Using PCR method, 17 out of 200 (8.5%) 
samples of spontaneous aborted placenta 
were found to be positive for T. gondii (Tab 
1, Figure 2).  
npcr results and data from questionnaires 
were analyzed employing Chi-square 
statistical test with 95% confidence interval 
using SPSS software version 16. A 
significant relationship was not observed 
between the presences of Toxoplasma, 
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mother's age, and history of abortion, 
gestational age and illnesses such as 





Fig 1: History of disease in abortive women 
 
Table 1: Demographic characteristics of mothers who had abortion and results of diagnostic technique 




37  4 43 ≤20  Age groups(yr)  
79  7 88 20-30 
62  6 69 >30 
95 11 106 1st trimester  Gestational age  
54 8 62 2th trimester  
30 2  32 3th trimester  
55 3 58 Yes History of 
abortion 
  
124 18 142 No 
 
 
Fig. 2: Agarose gel electrophoresis of nested PCR products of tissue samples of placenta of abortive women with the 
internal GRA6 primers. Lane M molecular marker, lane 1 Toxoplasma gondii positive control, lane 2  negative 




History of disease   
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DISCUSSION  
In order to definitely assess or rule out the 
diagnosis of congenital toxoplasmosis, a 
whole set 
of recommendations applies: i) prenatal 
diagnosis based on molecular testing of 
amniotic fluid and ultrasound 
examinations; ii) molecular testing of 
placenta and cord blood, comparative 
mother–child serologic tests and a clinical 
examination at birth; iii) neurologic and 
ophthalmologic examinations and a 
serologic survey during the first year of life 
(17). One third of mothers who acquire a 
primary T.gondii infection during 
pregnancy transmit the infection to their 
fetuses (18). 
 Transplacental infection of the fetus occurs 
in 12% of cases in which the mothers 
acquire infection during the first trimester 
(19).  
Recently, the value of PCR examination of 
placenta was compared to their inoculation 
into mice (Bessières et al, 2009). The 
sensitivity and specificity of PCR on 
placenta were 52% and 99% respectively, 
which was equal to that obtained by the 
mouse inoculation whereas the combination 
of PCR and mouse inoculation of placenta 
raised the sensitivity to57% (20). Placental 
examination by PCR and mouse 
inoculation was reported to be an efficient 
tool for the early diagnosis of CT in 
neonates (21).  
Placenta from infected women were 
analyzed to detect T. gondii by PCR, and 
the results were compared to those of the 
other samples collected at birth as cord 
blood and newborn blood. Ninety-four 
placenta,  were analyzed by in vitro culture, 
mouse inoculation, and PCR . The PCR 
sensitivity was higher than that of cell 
culture and mouse inoculation but the false-
positive PCR results were also higher (22).  
Suzuki et al confirmed IgM by detection of 
the Toxoplasma SAG1 gene in placenta and 
concluded that PCR using the placental 
tissue might be useful for the rapid 
diagnosis of congenital toxoplasmosis by 
detection of the Toxoplasma SAG1 gene by 
PCR in placenta. (23). 
The dense granules (GRA) are parasitic 
organelles involved in cell invasion and in 
the intracellular survival of the parasite. 
GRA proteins are expressed by the three 
stages of T. gondii: the tachyzoite, 
bradyzoite (24), and sporozoite (25) stages. 
GRA6 is a GRA antigen of 32 kDa 
described for the first time by Lecordier et 
al. (38). In extracellular parasites, GRA6 
exists in dense secretor granules mostly as 
soluble proteins. Like the other GRA 
proteins, GRA6 is involved in host cell 
invasion. GRA6 is a glycine-rich protein 
and behaves like an integral membrane 
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protein within the parasitophorous vacuole 
(26, 27).  
Rate of infection in pregnant women in Iran 
is relatively high. This rate in Zahedan, 
southeast of Iran, was reported to be 27% 
while in north of the country was 43.8% 
(28-29).  
In Shiraz, Southern Iran, the seroprevalence 
of toxoplasmosis among pregnant women 
was reported to be 77.2% (30). 
The rate of Toxoplasma infection in aborted 
placenta in Shiraz in the other study was 
14.4 %( 31). 
Study by Hoveyda showed in out of 65 
delivery product 15.48% was positive for 
Toxoplasma gondii by PCR teqnique in 
Isfahan, Iran (32).  
 A study on seroprevalence of 
toxoplasmosis in Kosovo in pregnant 
women demonstrated that 1.2% of women 
acquired toxoplasmosis during their 
pregnancy (33).  
In other studies transmission rate to the 
children in the Finland was 40 %( 34). 
Direct detection of T. gondii in clinical 
samples confirms the parasite presence 
leading to the diagnosis of primary, 
reactivated or chronic toxoplasmosis (35). 
In this study, the rate of Toxoplasma 
infection in aborted placenta was 8.5%. 
This is lower than the rates that have been 
reported for abortion due to toxoplasmosis 
in other studies in Iran (31, 32). Prevalence 
of Toxoplasmosis in region, type of sample, 
method of sampling, and size of sample 
may all affect the outcome of the 
experiment. 
In the present research similar to the results 
of previous studies (36, 37, 38, 39), there 
was no significant association between 
mothers’ age, history of abortion, 
gestational age, hypertension and existence 
of toxoplasma. 
CONCLUSION 
Our findings show that toxoplasmosis acts 
as a warning and main risk factor for 
increase the possibility of abortion in 
pregnant woman in this region of Iran and 
placenta analysis is important to improve 
the sensitivity of the diagnosis at birth, 
especially when the prenatal diagnosis was 
negative or not performed. 
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